ISDA

Deposition Date 2010-01-04

Release Date 2010-05-05

Last Version Date 2023-09-06

Entry Detail

PDB ID:

3L8V

Keywords:

TRANSFERASE

Title:

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-MET in complex with a biarylamine based inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

SPODOPTERA FRUGIPERDA

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.40 Å

R-Value Free:

0.23

R-Value Work:

0.18

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Hepatocyte growth factor receptor
Gene (Uniprot):MET
Chain IDs:A
Chain Length:314
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P08581 Pfam ID:PF07714 EC:2.7.10.1

Ligand Molecules

L8V

Primary Citation

Design, synthesis and structure-activity relationships of novel biarylamine-based Met kinase inhibitors.

Williams, D.K, Chen, X.T, Tarby, C, Kaltenbach, R, Cai, Z.W, Tokarski, J.S, An, Y, Sack, J.S, Wautlet, B, Gullo-Brown, J, Henley, B.J, Jeyaseelan, R, Kellar, K, Manne, V, Trainor, G.L, Lombardo, L.J, Fargnoli, J, Borzilleri, R.M.Show

Bioorg.Med.Chem.Lett. 20 2998 3002 (2010)

PMID: 20382527 DOI: 10.1016/j.bmcl.2010.01.042

Abstact

Biarylamine-based inhibitors of Met kinase have been identified. Lead compounds demonstrate nanomolar potency in Met kinase biochemical assays and significant activity in the Met-driven GTL-16 human gastric carcinoma cell line. X-ray crystallography revealed that these compounds adopt a bioactive conformation, in the kinase domain, consistent with that previously seen with 2-pyridone-based Met kinase inhibitors. Compound 9b demonstrated potent in vivo antitumor activity in the GTL-16 human tumor xenograft model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures